[HTML][HTML] The current advances of lncRNAs in breast cancer immunobiology research

MA Fonseca-Montaño, KI Vázquez-Santillán… - Frontiers in …, 2023 - frontiersin.org
Breast cancer is the most frequently diagnosed malignancy and the leading cause of cancer-
related death in women worldwide. Breast cancer development and progression are mainly …

[HTML][HTML] Long Non-Coding RNAs as Regulators for Targeting Breast Cancer Stem Cells and Tumor Immune Microenvironment: Biological Properties and Therapeutic …

F Yang, Y Yang, Y Qiu, L Tang, L Xie, X Guan - Cancers, 2024 - mdpi.com
Simple Summary A number of lncRNAs participate in the stemness-related signaling
pathways. In this article, we provided insights into the emerging data for the interaction …

[HTML][HTML] Exploring the regulatory role of lncRNA in cancer immunity

D Zhan, H Xian - Frontiers in Oncology, 2023 - frontiersin.org
Imbalanced immune homeostasis in cancer microenvironment is a hallmark of cancer.
Increasing evidence demonstrated that long non-coding RNAs (lncRNAs) have emerged as …

[HTML][HTML] Comprehensive Transcriptome Analysis Expands lncRNA Functional Profiles in Breast Cancer

W Zhu, H Huang, Z Hu, Y Gu, R Zhang, H Shu… - International Journal of …, 2024 - mdpi.com
Breast cancer is a heterogeneous disease that arises as a multi-stage process involving
multiple cell types. Patients diagnosed with the same clinical stage and pathological …

[HTML][HTML] lncRNA and breast cancer: Progress from identifying mechanisms to challenges and opportunities of clinical treatment

H Jin, W Du, W Huang, J Yan, Q Tang, Y Chen… - … Therapy-Nucleic Acids, 2021 - cell.com
Breast cancer is a malignant tumor that has a high mortality rate and mostly occurs in
women. Although significant progress has been made in the implementation of personalized …

Long non-coding RNA and the tumor microenvironment: prospects for clinical applications in breast cancer

Y Lei, J He, Y Tang - Critical Reviews in Oncology/Hematology, 2023 - Elsevier
Breast cancer has surpassed lung cancer as the number one cancer worldwide, and
invasion and metastasis are still the main causes of death in breast cancer patients. The …

Predicting the immune landscape of invasive breast carcinoma based on the novel signature of immunerelated lncRNA

S Shen, X Chen, X Hu, J Huo, L Luo… - Cancer Medicine, 2021 - Wiley Online Library
Background The composition of the population of immunerelated long noncoding
ribonucleic acid (irlncRNA) generates a signature, irrespective of expression level, with …

Four lncRNAs associated with breast cancer prognosis identified by coexpression network analysis

J Li, C Gao, C Liu, C Zhou, X Ma, H Li… - Journal of Cellular …, 2019 - Wiley Online Library
Previous studies on long noncoding RNA (lncRNA) have made breakthroughs in the
treatment of several tumors, and these findings have brought attention to the lncRNA …

LncRNAs exhibit subtype-specific expression, survival associations, and cancer-promoting effects in breast cancer

MCD Wasson, J Venkatesh, HF Cahill, ME McLean… - Gene, 2024 - Elsevier
Long non-coding RNAs (lncRNAs) play important roles in cancer progression, influencing
processes such as invasion, metastasis, and drug resistance. Their reported cell type …

[HTML][HTML] Immune-related lncRNAs as predictors of survival in breast cancer: a prognostic signature

W Ma, F Zhao, X Yu, S Guan, H Suo, Z Tao… - Journal of Translational …, 2020 - Springer
Background Breast cancer is a highly heterogeneous disease, this poses challenges for
classification and management. Long non-coding RNAs play acrucial role in the breast …